StanConnect2021: Biomedical Statistics
|
|
1
|
1738
|
September 23, 2021
|
Comparing 2 methods of measuring a parameter
|
|
0
|
1434
|
September 17, 2021
|
How to handle MNAR from a covariate due to witnessing the survival outcome?
|
|
2
|
2426
|
September 10, 2021
|
Statistical Peer Review
|
|
1
|
1923
|
September 6, 2021
|
Bayesian analysis of RCT data
|
|
12
|
9771
|
September 1, 2021
|
Diagnostics for regression models with splines
|
|
1
|
2712
|
August 24, 2021
|
Cox regression vs. competing risk regression?
|
|
9
|
11986
|
August 23, 2021
|
Plotting curves from a multi-state survival model
|
|
2
|
1831
|
August 18, 2021
|
Finding optimal time since event to administer treatment
|
|
0
|
832
|
August 7, 2021
|
Non inferiority Margin without Placebo controlled Trial
|
|
13
|
3034
|
August 2, 2021
|
Henry Ford Observational Study on HCQ in COVID-19-- failure of basic peer review
|
|
39
|
12905
|
July 15, 2021
|
Providing starting values for geepack::geeglm
|
|
1
|
49905
|
July 8, 2021
|
Heterogeneity in RCTs with continuous outcome
|
|
19
|
10061
|
July 2, 2021
|
Multiple Imputation - chi2
|
|
3
|
3222
|
June 28, 2021
|
Forest plot for Multi-state cox model
|
|
2
|
2613
|
June 25, 2021
|
Sparse data with zero cells in logistic regression model
|
|
4
|
6270
|
June 23, 2021
|
Meta-analysis of time-to-event data for single group design
|
|
5
|
3702
|
June 17, 2021
|
Calculation of Sample Size for Survival: Logrank vs. Cox with covariates
|
|
2
|
3355
|
June 17, 2021
|
Modeling pre-post intervention changes with no control
|
|
9
|
3642
|
June 8, 2021
|
Statistical foundations/theory book recommendation(s)
|
|
4
|
2271
|
May 29, 2021
|
The distinction between sample description (summarization) and point estimation
|
|
3
|
2337
|
May 9, 2021
|
Association of continuous outcomes with binary endpoints; and "optimal" cut-off points
|
|
3
|
2818
|
May 3, 2021
|
Calculating time to event variable
|
|
0
|
1721
|
April 29, 2021
|
Hazard ratio and absolute difference
|
|
2
|
2926
|
April 21, 2021
|
Confusing results from Scottish study of real-world effectiveness of Pfizer and Oxford/ Astra Zeneca vaccines
|
|
1
|
2249
|
March 8, 2021
|
Musing on how to design "statistical functions/methods 2.0"
|
|
3
|
2143
|
March 7, 2021
|
Advice on study design
|
|
6
|
4261
|
March 3, 2021
|
ANDROMEDA-SHOCK (or, how to intepret HR 0.76, 95% CI 0.55-1.02, p=0.06)
|
|
73
|
27091
|
January 27, 2020
|
Bootstrap on regression models
|
|
11
|
12437
|
January 27, 2021
|
Causal use of prediction models
|
|
1
|
2224
|
January 26, 2021
|